| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 15050943
[patent_doc_number] => RE047672
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-10-29
[patent_title] => Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
[patent_app_type] => reissue
[patent_app_number] => 15/697069
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32598
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15697069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/697069 | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 | Sep 5, 2017 | Issued |
Array
(
[id] => 16562689
[patent_doc_number] => RE048389
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2021-01-12
[patent_title] => Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
[patent_app_type] => reissue
[patent_app_number] => 15/697146
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 33
[patent_no_of_words] => 35197
[patent_no_of_claims] => 110
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15697146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/697146 | Antibody drug conjugates (ADC) that bind to 191P4D12 proteins | Sep 5, 2017 | Issued |
| 15/697074 | METHODS OF IMPAIRING OSTEOCLAST DIFFERENTIATION USING ANTIBODIES THAT BIND SIGLEC-15 | Sep 5, 2017 | Abandoned |
| 90/014003 | CRISPR/CAS SYSTEMS FOR GENOMIC MODIFICATION AND GENE MODULATION | Aug 23, 2017 | Issued |
Array
(
[id] => 15189749
[patent_doc_number] => RE047751
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-12-03
[patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof
[patent_app_type] => reissue
[patent_app_number] => 15/655646
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15757
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/655646 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Jul 19, 2017 | Issued |
| 90/013986 | PLACENTAL TISSUE GRAFTS | Jul 13, 2017 | Issued |
Array
(
[id] => 15066919
[patent_doc_number] => RE047691
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-11-05
[patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof
[patent_app_type] => reissue
[patent_app_number] => 15/645842
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20660
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645842 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Jul 9, 2017 | Issued |
Array
(
[id] => 16588594
[patent_doc_number] => RE048404
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2021-01-26
[patent_title] => Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
[patent_app_type] => reissue
[patent_app_number] => 15/642307
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4305
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642307
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/642307 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | Jul 4, 2017 | Issued |
| 15/588382 | COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASE | May 4, 2017 | Abandoned |
| 90/013940 | DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING COUPLED POLYMERASE CHAIN REACTIONS | Apr 12, 2017 | Issued |
| 90/013937 | DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING COUPLED LIGASE DETECTION AND POLYMERASE CHAIN REACTIONS | Apr 11, 2017 | Issued |
Array
(
[id] => 13192929
[patent_doc_number] => RE047103
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-10-30
[patent_title] => Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
[patent_app_type] => reissue
[patent_app_number] => 15/448507
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 26
[patent_no_of_words] => 34539
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448507
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448507 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | Mar 1, 2017 | Issued |
| 15/405171 | METHOD FOR TREATING ONYCHOMYCOSIS | Jan 11, 2017 | Abandoned |
Array
(
[id] => 14084277
[patent_doc_number] => RE047320
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-03-26
[patent_title] => Modulation of CD40 expression
[patent_app_type] => reissue
[patent_app_number] => 15/386791
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22018
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15386791
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/386791 | Modulation of CD40 expression | Dec 20, 2016 | Issued |
Array
(
[id] => 15242481
[patent_doc_number] => RE047769
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-12-17
[patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof
[patent_app_type] => reissue
[patent_app_number] => 15/349535
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16555
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349535 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Nov 10, 2016 | Issued |
Array
(
[id] => 15242479
[patent_doc_number] => RE047768
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-12-17
[patent_title] => Compositions and methods for the production of alpha-herpesviruses
[patent_app_type] => reissue
[patent_app_number] => 15/344216
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 6060
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/344216 | Compositions and methods for the production of alpha-herpesviruses | Nov 3, 2016 | Issued |
| 90/013857 | GENETICALLY ENGINEERED OR TRANSGENIC RATS EXHIBITING A CANCER PHENOTYPE DUE TO A DISRUTPTION OF GERMLINE TUMOR SUPPRESSOR GENES | Nov 2, 2016 | Issued |
Array
(
[id] => 15223695
[patent_doc_number] => RE047761
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-12-10
[patent_title] => Anti-axl antibodies and methods of use
[patent_app_type] => reissue
[patent_app_number] => 15/287601
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 39
[patent_no_of_words] => 40245
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287601
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287601 | Anti-axl antibodies and methods of use | Oct 5, 2016 | Issued |
Array
(
[id] => 13941137
[patent_doc_number] => RE047245
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-02-19
[patent_title] => Pro-angiogenic peptides and uses thereof
[patent_app_type] => reissue
[patent_app_number] => 15/278016
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 9021
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15278016
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/278016 | Pro-angiogenic peptides and uses thereof | Sep 26, 2016 | Issued |
| 15/268332 | B7-H1 Antibodies and Method of Use | Sep 15, 2016 | Abandoned |